Nevertheless, most of these studies also found a correlation of PD-L1 expression with type B histology [33,34,41,42,43,44,47,49,50] (in concordance with our results), which suggests a nonredundant application of immunotherapy for these aggressive types of thymomas. This evidence concerns the gene CD274 and thymoma.